Alerts
Modified Hours for Independence Day Observance

In recognition of the upcoming Independence Day holiday, some of The University of Kansas Cancer Center's offices will have modified hours on Friday, July 4.

Skip Navigation

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC NeoTRACT

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05645380

Study #:
STUDY00149312

Start Date:
Dec 05, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05645380

View Complete Trial Details & Eligibility at ClinicalTrials.gov